Pharmacokinetics of Hu5F9-G4, a first-in-class anti-CD47 antibody, in patients with solid tumors and lymphomas. Agoram, B., Wang, B., Sikic, B. I., Lakhani, N. J., Patnaik, A., Liu, J., Secreto, R., Chao, M., Takimoto, C. M. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.2525

View details for Web of Science ID 000442916001305